Word

PHANES THERAPEUTICS

Status

Dead

Status Code

606

Status Date

Monday, April 5, 2021

Serial Number

87555473

Mark Type

3000

Filing Date

Thursday, August 3, 2017

Published for Opposition

Tuesday, January 2, 2018

Abandoned Date

Monday, April 5, 2021

Trademark Owner History

Phanes Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Tumor suppressing agents; Clinical medical reagents; Anti-diabetic pharmaceuticals; Anti-cancer preparations; Cellular function activating agents for medical purposes

Color is not claimed as a feature of the mark.
"THERAPEUTICS"
The mark consists of a human figure whose left hand raising a DNA pattern, the wording "PHANES" which is at the right of the human figure and the wording "THERAPEUTICS" which is at the lower right of "PHANES".

Trademark Events

Apr 5, 2021

Abandonment Notice E-Mailed - No Use Statement Filed

Apr 5, 2021

Abandonment - No Use Statement Filed

Aug 19, 2020

Notice Of Approval Of Extension Request E-Mailed

Aug 18, 2020

Extension 5 Granted

Aug 14, 2020

Extension 5 Filed

Aug 18, 2020

Case Assigned To Intent To Use Paralegal

Aug 14, 2020

Teas Extension Received

Feb 13, 2020

Notice Of Approval Of Extension Request E-Mailed

Feb 11, 2020

Extension 4 Granted

Feb 11, 2020

Extension 4 Filed

Feb 11, 2020

Teas Extension Received

Aug 7, 2019

Notice Of Approval Of Extension Request E-Mailed

Aug 5, 2019

Extension 3 Granted

Aug 5, 2019

Extension 3 Filed

Aug 5, 2019

Teas Extension Received

Feb 14, 2019

Notice Of Approval Of Extension Request E-Mailed

Feb 12, 2019

Extension 2 Granted

Feb 12, 2019

Extension 2 Filed

Feb 12, 2019

Teas Extension Received

Nov 27, 2018

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 27, 2018

Teas Change Of Owner Address Received

Jul 17, 2018

Notice Of Approval Of Extension Request E-Mailed

Jul 13, 2018

Extension 1 Granted

Jul 13, 2018

Extension 1 Filed

Jul 13, 2018

Teas Extension Received

Feb 27, 2018

Noa E-Mailed - Sou Required From Applicant

Jan 2, 2018

Official Gazette Publication Confirmation E-Mailed

Jan 2, 2018

Published For Opposition

Dec 13, 2017

Notification Of Notice Of Publication E-Mailed

Nov 27, 2017

Assigned To Lie

Nov 15, 2017

Approved For Pub - Principal Register

Nov 15, 2017

Teas/Email Correspondence Entered

Nov 14, 2017

Correspondence Received In Law Office

Nov 14, 2017

Teas Response To Office Action Received

Nov 12, 2017

Notification Of Non-Final Action E-Mailed

Nov 12, 2017

Non-Final Action E-Mailed

Nov 12, 2017

Non-Final Action Written

Nov 3, 2017

Assigned To Examiner

Aug 10, 2017

Notice Of Design Search Code E-Mailed

Aug 9, 2017

New Application Office Supplied Data Entered In Tram

Aug 7, 2017

New Application Entered In Tram